Xylem Inc’s filing revealed that its Director Harker Victoria D unloaded Company’s shares for reported $0.26 million on Aug 04 ’25. In the deal valued at $143.63 per share,1,800 shares were sold. As a result of this transaction, Harker Victoria D now holds 18,575 shares worth roughly $2.65 million.
Then, VICTORIA HARKER bought 1,800 shares, generating $258,542 in total proceeds.
Before that, JEANNE BELIVEAU-DUNN bought 8,453 shares. Xylem Inc shares valued at $1,079,327 were divested by the Officer at a price of $127.69 per share.
JP Morgan initiated its Xylem Inc [XYL] rating to an Overweight in a research note published on May 30, 2025; the price target was $148. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid December from “an Outperform” to “a Peer perform”. Citigroup also remained covering XYL and has increased its forecast on December 09, 2024 with a “Buy” recommendation from previously “Neutral” rating. TD Cowen revised its rating on September 03, 2024. It rated XYL as “a Hold” which previously was an “a Buy”.
Price Performance Review of XYL
On Monday, Xylem Inc [NYSE:XYL] saw its stock jump 0.15% to $142.87. Over the last five days, the stock has lost -0.76%. Xylem Inc shares have risen nearly 12.65% since the year began. Nevertheless, the stocks have risen 23.14% over the past one year. While a 52-week high of $145.33 was reached on 08/05/25, a 52-week low of $100.47 was recorded on 04/07/25.
Levels Of Support And Resistance For XYL Stock
The 24-hour chart illustrates a support level at 142.11, which if violated will result in even more drops to 141.34. On the upside, there is a resistance level at 143.30. A further resistance level may holdings at 143.72.
How much short interest is there in Xylem Inc?
A steep rise in short interest was recorded in Xylem Inc stocks on 2025-07-15, dropping by -0.16 million shares to a total of 2.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 2.34 million shares. There was a decline of -7.48%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 13, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $165 price target.
